Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000244 · ClinicalTrials.gov registry record · Phase 2
Effects of Dynorphin 1-13 on Heroin Addiction - 1
A Phase 2 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000244: Completed Phase 2 study, sponsored by University of Minnesota.
NCT00000244 is a Phase 2 study that has completed, run by University of Minnesota. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000244, a Phase 2 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to evaluate the effects of IV dynorphin in humans during acute heroin abstinence, in order to determine that dynorphin suppresses acute opiate withdrawal, reduces opiate craving, and is safe at doses required to produce the above effects.
Interventions
- DRUG Dynorphin 1 - 13
Trial Details
| Field | Value |
|---|---|
| Start Date | 1994-08 |
| Est. Completion | 1997-03 |
| Phase | Phase 2 |
What the finished NCT00000244 record still lists
NCT00000244 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Dynorphin 1 - 13 is the first listed.
NCT00000244 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000244 about?
NCT00000244 is a clinical study titled "Effects of Dynorphin 1-13 on Heroin Addiction - 1". The purpose of this study is to evaluate the effects of IV dynorphin in humans during acute heroin abstinence, in order to determine that dynorphin suppresses acute opiate withdrawal, reduces opiate craving, and is safe at doses required to produce the above effects.
What is the current status of trial NCT00000244?
This trial is currently completed. It is a Phase 2 study. The study started on 1994-08. Estimated completion is 1997-03.
What interventions are being tested in trial NCT00000244?
The interventions under investigation include: Dynorphin 1 - 13 (DRUG).
Who is sponsoring clinical trial NCT00000244?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia